FDA Brief

Company record

Aspen Aesthetics dba Fifty 410

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Aspen Aesthetics dba Fifty 410.

Warning letters

  1. Aspen Aesthetics dba Fifty 410

    FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.

    Low